Matsehora, N. A., & Mitasova, Y. (2017). Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear.
Chicago Style (17th ed.) CitationMatsehora, N. A., and Yu Mitasova. Rationale for the Differentiated Appointment of Vazoactive Preparations in the Treatment of Patients with Ischemic Heart Disease in Combination with Arterial Hypertension Dependent on the Degree of Pulmonary Hypertension and / or the Stage of Chronic Hear. 2017.
MLA (8th ed.) CitationMatsehora, N. A., and Yu Mitasova. Rationale for the Differentiated Appointment of Vazoactive Preparations in the Treatment of Patients with Ischemic Heart Disease in Combination with Arterial Hypertension Dependent on the Degree of Pulmonary Hypertension and / or the Stage of Chronic Hear. 2017.